Market Currents
Barclays takes a dimmer view of shares of Pfizer (PFE), downgrading the drugmaker to Equal...
-
Wednesday, September 14, 2011, 7:55 AM ETBarclays takes a dimmer view of shares of Pfizer (PFE), downgrading the drugmaker to Equal Weight and cutting its price target by $2 to $19. Analysts see limited upside potential in the near-term, and say patent expiration will kick in and pressure the firm in the long-term. Shares -0.5% premarket.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
